This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (35)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jonathan K. Wilkin, MD; Walter M. Kirkendall, MD

Arch Dermatol. 1982;118(3):186-187.

Abstract
• Captopril, an orally active dipeptidylcarboxypeptidase inhibitor, is a promising new antihypertensive agent. Cutaneous reactions, including (rarely) a pityriasis rosea-like eruption, are frequently associated with this therapy. Two new cases of a pityriasis rosea-like captopril-induced eruption support a pharmacologic mechanism for the eruption, since it resolved after the dosage of captopril was lowered in one patient and continued when the dosage of captopril remained unchanged in the other patient. However, the eruption later responded to therapy while use of the drug was continued. Captopril should be included among those drugs associated with a pityriasis rosea-like eruption.

(Arch Dermatol 1982;118:186-187)

Author Affiliations
From the Departments of Dermatology (Dr Wilkin) and Medicine (Dr Kirkendall), University of Texas Health Science Center, Houston.

Footnotes
Accepted for publication June 19, 1981.

Reprint requests to 1.202 Medical School Main Bldg, 6431 Fannin, Houston, TX 77030 (Dr Wilkin).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pemphigus-like Eruption From Captopril
Katz et al.
Arch Dermatol 1987;123:20-21.
ABSTRACT  

Dermatologic Problems in the Intensive Care Unit: Part IV
Berman and Silvestri
J Intensive Care Med 1986;1:224-239.
ABSTRACT